NDC 47335-038 – Bosentan
Bosentan 62.5 mg/1 · Tablet, Film Coated · Oral
Product NDC47335-038
Product details
- Brand name
- Bosentan
- Generic name
- Bosentan
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA209324
- Marketed since
- April 26, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Endothelin Receptor Antagonist
Active ingredients
- Bosentan 62.5 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 47335-038-64 | 10 BLISTER PACK in 1 CARTON (47335-038-64) / 3 TABLET, FILM COATED in 1 BLISTER PACK (47335-038-60) | Apr 26, 2019 |
| 47335-038-86 | 60 TABLET, FILM COATED in 1 BOTTLE (47335-038-86) | Apr 26, 2019 |
Other Bosentan products
- 0591-2511 Bosentan 62.5 mg/1 · Tablet, Film Coated · Actavis Pharma, Inc.
- 0591-2512 Bosentan 125 mg/1 · Tablet, Film Coated · Actavis Pharma, Inc.
- 68180-340 Bosentan 32 mg/1 · Tablet, For Suspension · Lupin Pharmaceuticals, Inc.
- 47335-039 Bosentan 125 mg/1 · Tablet, Film Coated · Sun Pharmaceutical Industries, Inc.
- 70771-1017 Bosentan 62.5 mg/1 · Tablet · Zydus Lifesciences Limited
- 70771-1018 Bosentan 125 mg/1 · Tablet · Zydus Lifesciences Limited
- 70771-1908 Bosentan 32 mg/1 · Tablet, For Suspension · Zydus Lifesciences Limited
- 68382-446 Bosentan 62.5 mg/1 · Tablet, Coated · Zydus Pharmaceuticals USA Inc.
- 68382-447 Bosentan 125 mg/1 · Tablet, Coated · Zydus Pharmaceuticals USA Inc.
- 70710-1508 Bosentan 32 mg/1 · Tablet, For Suspension · Zydus Pharmaceuticals USA Inc.